Targeting the Sanctuary Site: Options when Breast Cancer Metastasizes to the Brain

Insights

Brain metastases significantly worsen breast cancer prognosis, with limited treatment success. This review covers risk, current therapies, and emerging strategies for improved outcomes in breast cancer brain metastases.

Area of Science:

  • Oncology
  • Neurology
  • Cancer Research

Background:

  • Brain metastasis is a critical challenge in advanced breast cancer, associated with poor prognosis and low survival rates.
  • Increasing survival due to treatment advancements paradoxically leads to a higher incidence of brain metastases.
  • Established treatments, including anti-HER2 agents, show limited efficacy against brain metastases compared to other sites.

Purpose of the Study:

  • To provide a comprehensive review of breast cancer brain metastases.
  • To discuss risk factors, therapeutic selection, and current/emerging treatments.
  • To present a multidisciplinary treatment paradigm incorporating molecular characteristics.

Main Methods:

  • Literature review of current evidence on breast cancer brain metastases.
  • Analysis of risk factors stratified by breast cancer subtype.
  • Evaluation of focal and systemic treatment options and novel therapeutic targets.

Main Results:

  • Breast cancer brain metastases represent a significant clinical challenge with poor outcomes.
  • Novel therapies are emerging, offering potential improvements over traditional treatments.
  • Understanding molecular characteristics is crucial for effective treatment selection.

Conclusions:

  • A multidisciplinary approach integrating molecular insights is essential for managing breast cancer brain metastases.
  • Further research into novel therapies and targets is critical to improve patient survival and quality of life.
  • Personalized treatment strategies are key to overcoming the challenges posed by brain metastases in breast cancer.

Related Concept Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

We describe a xenograft mouse model of breast cancer brain metastasis generated via tail-vein injection of an endogenously HER2-amplified inflammatory breast cancer cell...
3.8K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Here, we describe the protocol for in vivo delivery of magnetic iron oxide nanoparticles carrying RNA oligomers to metastatic breast cancer in animal models, providing a clinically viable approach for the therapeutic silencing of oncogenic nucleic...
741
Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI08:36

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

A breast cancer brain metastasis mouse model is established with ultrasound imaging-guided intracardiac injection of MDA-MB231/Br-GFP cells. Development of multifocal intracranial metastases has been monitored longitudinally using high-resolution 9.4 T...
19.6K
Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Activation of latent mutations with adenovirus-Cre into the mammary ductal system results in a clinically relevant metastatic breast cancer. Incorporation of a YFP promoter allows tracking of distal metastatic tumor cells. This model is useful to study latent metastasis, anti-tumor immunity, and for designing novel immunotherapies to treat breast...
23.9K
An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth10:38

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth

We introduce a protocol for measuring real-time drug and radiation response of breast cancer brain metastatic cells in an organotypic brain slice model. The methods provide a quantitative assay to investigate the therapeutic effects of various treatments on brain metastases from breast cancer in an ex vivo manner within the brain microenvironment interface.
3.7K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

This work presets an advanced protocol to accurately assess tumor loading by detection of green fluorescent protein and bioluminescence signals as well as the integration of quantitative molecular detection...
18.8K